Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update: Secondary Sale and

7 Apr 2022 07:00

JZ Capital Partners Ltd - Update: Secondary Sale and

JZ Capital Partners Ltd - Update: Secondary Sale and

PR Newswire

London, April 7

JZ CAPITAL PARTNERS LIMITED (the "Company" or "JZCP")(a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registered number 48761)LEI 549300TZCK08Q16HHU44

Update in relation to Secondary Sale and

Monthly Net Asset Value

7 April 2022

JZ Capital Partners Limited, the London listed fund that has investments in US and European microcap companies and US real estate, is today pleased to provide an update in relation to its interest in the secondary fund, JZHL Secondary Fund LP (the "Secondary Fund") to which JZCP sold its interests in certain US microcap portfolio companies (the "Secondary Sale"). The Secondary Sale was announced on 19 October 2020, with further details of the sale being included in a circular sent to shareholders of the Company dated 29 October 2020.

The Secondary Fund has sold its interest in Flow Control Holdings LLC ("Flow Control") for consideration of approximately US$77.7 million. This transaction confers no immediate cash benefit to JZCP because, as described below, the other investors in the Secondary Fund (the "Secondary Investors") have an entitlement to a priority return before any distribution may be made to JZCP. However, as a result of the distribution to the Secondary Investors from the sale of Flow Control the amount of the outstanding priority return has been reduced to approximately US$35.5 million. Excluding Flow Control, the remaining investments in the Secondary Fund are, subject to audit, held at approximately US$256.5 million as at 28 February 2022. JZCP’s interest in the Secondary Fund based on pro forma financials as at 28 February 2022 is valued at approximately US$117.3 million.

As detailed in the aforementioned announcement and circular, JZCP received as consideration for the Secondary Sale, and in addition to the already received approximately US$90 million in cash, a special limited partner interest in the Secondary Fund entitling JZCP to certain distributions and other rights and obligations from the Secondary Fund (the "Special LP Interest"). Any distributions to be received by JZCP as a result of its Special LP Interest are subject to an agreed distribution waterfall as detailed in the aforementioned announcement and circular which provides that, once the Secondary Investors have received their initial required distributions determined by reference to their respective contributions to the Secondary Fund and amounting to approximately US$132.6 million, in aggregate, JZCP will be entitled to receive as distributions from the Secondary Fund: (i) 95 per cent. of all distributions until it has received distributions equal to US$67.6 million; and (ii) thereafter, 37.5 per cent. of all distributions.

The sale of Flow Control will result in the Secondary Investors receiving a distribution from the Secondary Fund of approximately US$77.7 million which, together with other distributions so far made and received, will amount to distributions totalling approximately US$97.1 million for the benefit of the Secondary Investors. The Secondary Investors are therefore still entitled to receive further distributions from the Secondary Fund totalling approximately US$35.5 million before JZCP becomes entitled to any distributions as a result of its Special LP Interest and in accordance with the distribution waterfall as described above.

The Company will make further announcements concerning the distributions of the Secondary Fund (and in particular concerning any distributions as a result of its Special LP Interest) as and when appropriate and once further information becomes available to it.

Update in relation to Monthly Net Asset Value

On 23 March 2022, the Company announced that its unaudited Net Asset Value ("NAV") per Ordinary Share of the Company as at the close of business on 28 February 2022 was US$ 4.16.

The sale of Flow Control has resulted in an uplift to the Company's unaudited NAV per Ordinary Share of the Company as at the close of business on 28 February 2022 of 24 cents per share, as follows:

Company NameDateNAV per Ordinary Share
JZ Capital Partners Limited28 February 2022US$ 4.40

The Company’s annual results are currently being audited and the above NAV is therefore subject to change.

______________________________________________________________________________________

For further information:

Kit Dunford / Ed Berry FTI Consulting+44 (0)7717 417 038 / +44 (0)7703 330 199
David Zalaznick Jordan/Zalaznick Advisers, Inc.+1 (212) 485 9410
Sam Walden / Martin Chapman Northern Trust International Fund Administration Services (Guernsey) Limited+44 (0) 1481 745385 / +44 (0)1481 745183
Date   Source Headline
18th May 20127:00 amRNSFull Year Results 2011
17th May 20127:00 amRNSNet Asset Value(s)
27th Apr 20129:07 amRNSNet Asset Value(s)
17th Apr 20124:04 pmRNSNotice of Results - Replacement
13th Apr 20128:57 amRNSNotice of Results
24th Feb 201210:05 amRNSNew Accounting Ref Date
23rd Feb 20129:23 amRNSNet Asset Value(s)
25th Jan 20125:02 pmRNSHolding(s) in Company
25th Jan 20122:17 pmRNSTotal Voting Rights
20th Jan 20124:49 pmRNSHolding(s) in Company
19th Jan 20125:31 pmRNSDirector/PDMR Shareholding
19th Jan 20125:30 pmRNSDirector/PDMR Shareholding
19th Jan 20125:29 pmRNSDirector/PDMR Shareholding
19th Jan 20125:27 pmRNSDirector/PDMR Shareholding
17th Jan 20129:22 amRNSNet Asset Value(s)
16th Jan 201211:46 amRNSHolding(s) in Company
10th Jan 20123:33 pmRNSHolding(s) in Company
29th Dec 201110:03 amRNSHolding(s) in Company
28th Dec 20119:34 amRNSNet Asset Value(s)
22nd Dec 20115:23 pmRNSDirector/PDMR Shareholding
22nd Dec 20119:43 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSJZCP Q3 Interim Management Statement
14th Dec 201111:23 amRNSHolding(s) in Company
6th Dec 20111:58 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSCompletes Sale of Wound Care Holdings LLC
1st Dec 20119:17 amRNSConversion of Securities
23rd Nov 20114:17 pmRNSNet Asset Value(s)
31st Oct 20119:52 amRNSNet Asset Value(s)
25th Oct 20112:55 pmRNSDisposal
20th Oct 20114:28 pmRNSHolding(s) in Company
19th Oct 20112:02 pmRNSDividend Declaration
18th Oct 20113:58 pmRNSNet Asset Value(s)
18th Oct 20117:00 amRNSInterim Results 2011
10th Oct 201110:48 amRNSHolding(s) in Company
5th Oct 20119:25 amRNSHolding(s) in Company
27th Sep 20119:28 amRNSHolding(s) in Company
16th Sep 20118:58 amRNSNotice of Interim Results
25th Aug 20117:00 amRNSConversion of Shares
12th Aug 20118:18 amRNSNet Asset Value(s)
18th Jul 20117:00 amRNSAcquisition and realisation of Investments
13th Jul 20118:30 amRNSNet Asset Value(s)
28th Jun 20115:01 pmRNSResult of AGM
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.